Daewoong Pharmaceutical, 7.21% Rise Amid COVID-19 (Camostat) Theme Uptrend
On the 9th, the COVID-19 (Camostat) theme rose by 3.24% compared to the previous day, showing strength, while Daewoong Pharmaceutical, which is attracting attention as a related stock, surged by 7.21% compared to the previous day. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling medicines such as Urusa and Albis.
[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong Pharmaceutical ranked 2nd out of 4 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Daewoong Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.
[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- Chairman Gu Jayeol: "Korea and Japan Need Cooperation in Power, Minerals, and AI... Let's Create a Second JAKO Project"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.